Table 4. Univariable and Multivariable analysis (dependent variable: overall survival).
| Covariates | Univariable | Multivariable | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Coefficient | HR | 95% CI | P value | Coefficient | HR | 95% CI | P value | ||
| Sex (male vs. female) | 0.42 | 1.52 | 0.81–2.84 | 0.19 | |||||
| No active lymphoma (yes vs. not) | 0.79 | 2.19 | 1.16–4.14 | 0.0152 | 1.00 | 2.68 | 1.36–5.26 | 0.0043 | |
| Age at Lymphoma diagnosis (≤39 vs. ≥40 years) | −0.03 | 0.97 | 0.74–1.29 | 0.85 | |||||
| Type of lymphoma (HL vs. NHL) | 0.56 | 0.34 | 0.63–1.69 | 0.76 | |||||
| Stage of lymphoma (stage I–II vs. stage III–IV) | 1.59 | 1.95 | 1.68–2.03 | 0.01 | 0.67 | 0.98 | 0.97–2.96 | 0.78 | |
| Treatment of lymphoma (RT alone vs. others) | −0.19 | 0.83 | 0.63–1.09 | 0.18 | |||||
| Age at NSCLC diagnosis (≤59 vs. ≥60 years) | 0.21 | 1.24 | 0.87–1.76 | 0.24 | |||||
| Incidental diagnosis of lung cancer (yes vs. not) | 0.54 | 1.71 | 1.41–2.08 | <0.0001 | 0.69 | 2.00 | 1.48–2.70 | <0.0001 | |
| Histology of NSCLC (adenocarcinoma vs. others) | −0.52 | 0.59 | 0.36–0.98 | 0.0421 | 0.19 | 1.20 | 0.67–2.15 | 0.53 | |
| NSCLC stage (stage I–II vs. stage III–IV) | 1.16 | 3.18 | 2.28–4.24 | <0.0001 | 0.86 | 2.37 | 1.60–3.51 | <0.0001 | |
| Lung cancer resection (yes vs. not) | −2.45 | 2.79 | 2.98–3.65 | <0.0001 | 0.86 | 2.07 | 1.51–2.75 | <0.0001 | |
HL, Hodgkin lymphoma; NHL, non-Hodgkin lymphoma; RT, radiotherapy; NSCLC, non-small cell lung cancer.